Close
Nordic 9Nordic 9

Marigold Investment Management (investor - Venture Capital)

Denmark mgim.dk
See something wrong or missing? Let us know
Offices:Copenhagen
Average round investment:2.17M USD
Average number per year:2.0
Distribution: 2025 (2)
Portfolio companies: Denmark Kripthonite TherapeuticsDenmark Zyneyro
Mostly invests in: Denmark Denmark (2) Health services (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Marigold Investment Management

Name Criteria
France Oskare Capital
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
United Kingdom Deepbridge Capital
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Denmark Innovationsfonden
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
Denmark North Ventures
82%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Sweden CBC Investment Group
82%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Sweden Enexis AB
82%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Rhia Ventures
81%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Denmark Unconventional Ventures
81%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 5.4
  • Active last 12 months: Yes
Denmark BioInnovation Institute
81%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 4.0
  • Active last 12 months: Yes
Sweden Länsförsäkringar
80%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Pharma, Biotech
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top